Mehmet Kamil GÖKER, Elif Merve ÖZCAN, Tunç AKKOÇ, Gökhan GÖÇMEN, Deniz GENÇ, İsmail Tayfun UZBAY, Burcu ÇEVRELİ, Noushin ZİBANDEH, Sertaç AKTOP, Emel SERDAROĞLU KAŞIKÇI, Nil ÇOMUNOĞLU ÜSTÜNDAĞ

Effects of Ankaferd BloodStopper on dermal healing in diabetic rats

Background/aim: Diabetes mellitus inhibits wound-induced angiogenesis, impairs the wound healing process, and leads to the development of chronic wounds. Ankaferd BloodStopper (ABS) is a new and promising local haemostatic agent. Although the mechanism of ABS-mediated haemostasis is well established, little is known about the associated histological and biochemical tissue reactions. The aim of this study was to evaluate the effects of this new-generation local haemostatic agent on short-term soft-tissue healing in streptozotocin (STZ)-treated rats. Materials and methods: The 24 Wistar albino rats used in this study were divided into STZ-treated (STZ, n = 12) and nontreated groups (control, n = 12). Four days prior to surgery, rats in the STZ group were subcutaneously administered 60 mg/kg STZ intraperitoneally, while rats in the control group were administered 1 mL saline/kg. An incision was made in the dorsal dermal tissue of all rats, and either ABS or no haemostatic agent (NHAA) was applied to the wound before suturing. All of the rats were euthanised on postoperative day 4. Blood and skin samples were evaluated biochemically and histologically. Results: The results showed that STZ treatment impaired soft-tissue healing, assessed by measuring glutathione and lipid peroxidation levels. Moreover, while good histological results were obtained in the control group treated with ABS, there were fewer benefits in the STZ-treated group. Conclusion: ABS s benefits in the control group seemed to lose their effectiveness under STZ medication.

PDF

___

1. Baynes YW, Thorpe R. Role of oxidative stress in diabetic complications. Diabetes 1999; 48: 1-9.
2. Koroglu P, Senturk GE, Yucel D, Ozakpinar OB, Uras F, Arbak S. The effect of exogenous oxytocin on streptozotocin (STZ)- induced diabetic adult rat testes. Peptides 2015; 63: 47-54.
3. Kanter M, Aktas C, Erboga M. Protective effects of quercetin against apoptosis and oxidative stress in streptozotocin induced diabetic rat testis. Food Chem Toxicol 2012; 50: 719-725.
4. İseri S, Gedik İ, Erzik C, Uslu B, Arbak S, Gedik N, Yegen B. Oxytocin ameliorates skin damage and oxidant gastric injury in rats with thermal trauma. Burns 2008; 34: 361-369.
5. Aktop S, Emekli-Alturfan E, Özer C, Gönül O, Garip H, Yarat A, Göker K. Effects of ankaferd blood stopper and celox on skin glutathione and lipid peroxidation levels in warfarintreated rat. Journal of Marmara University Institute of Health Sciences 2012; 2: 32-42 (article in Turkish with an abstract in English).
6. Mann K. The challenge of regulating anticoagulant drugs: focus on warfarin. Am Heart J 2005; 149: 536-542.
7. Abacıoğlu S, Aydın K, Büyükcam F, Kaya U, Işık B, Karakılıç ME. Comparison of the efficiencies of buffers containing Ankaferd and Chitosan on hemostasis in an experimental rat model with femoral artery bleeding. Turk J Hematol 2016; 33: 48-52.
8. Goker H, Haznedaroglu IC, Ercetin S, Kirazli S, Akman U, Ozturk Y, Firat HC. Haemostatic actions of the folkloric medicinal plant extract Ankaferd Blood Stopper. J Int Med Res 2008; 36: 163-170.
9. Aktop S, Emekli-Alturfan E, Gönül O, Göçmen G, Garip H, Yarat A, Göker K. Effect of Ankaferd Blood Stopper on Skin Superoxide Dismutase and Catalase Activities in WarfarinTreated Rats. Clin Appl Thromb Hemost 2015 Sep 8. DOI: 10.1177/1076029615604049.
10. Yamamoto N, Nishioka S, Sasai Y. Polarization microscopic investigation of collagen and acid glycosaminoglycans in the skin of progressive systemic sclerosis (PSS). Acta Histochem 1995; 97: 195-202.
11. Linares HA, Kischer CW, Dobrkovsky M, Larson DL. The histiotypic organization of the hypertrophic scar in humans. J Invest Dermatol 1972; 59: 323-331.
12. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25: 581-611.
13. Massagué J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295- 309.
14. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005; 23: 1011-1027.
15. Ferrari G, Pintucci G, Seghezzi G, Hyman K, Galloway AC, Mignatti P. VEGF, a prosurvival factor, acts in concert with TGF-beta1 to induce endothelial cell apoptosis. Proc Natl Acad Sci USA 2006; 103: 17260-17265.
16. Işler SC, Demircan S, Cakarer S, Cebi Z, Keskin C, Soluk M, Yüzbaşioğlu E. Effects of folk medicinal plant extract Ankaferd Blood Stopper on early bone healing. J Appl Oral Sci 2010; 18: 409-414.
17. Satar NY, Akkoc A, Oktay A, Topal A, Inan K. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats. Blood Coagul Fibrinolysis 2013; 24: 518-524.
18. Bulut E, Baş B, Altunkaynak BZ, Bekçioğlu B, Erdem Koç G, Gönülol E, Önger ME, Kaplan S. Efficacy of Ankaferd Blood Stopper on bone healing in diabetic rats: a stereological and histopathological study. Biotech Histochem 2014; 89: 535-543.
19. Yüce S, Celal C, Yenidunya S, Muslu B. New hemostatic agent: the effect of Ankaferd Blood Stopper on healing wounds in experimental skin incision model. Turk J Med Sci 2014; 44: 288-294.
20. Akalin C, Kuru S, Barlas AM, Kismet K, Kaptanoglu B, Demir A, Astarci HM, Ustun H, Ertas E. Beneficial effects of Ankaferd Blood Stopper on dermal wound healing: an experimental study. Int Wound J 2014; 11: 64-68.
21. Aydın BK, Altan E, Acar MA, Erkoçak ÖF, Ugraş S. Effect of Ankaferd blood stopper® on tendon healing: an experimental study in a rat model of Achilles tendon injury. Joint Diseases and Related Surgery 2015; 26: 31-37.
22. Beutler E. Glutathione: Red Cell Metabolism. A Manual of Biochemical Methods. 2nd edition. New York, NY, USA: Grune and Stratton, 1975; pp. 112-114.
23. Yagi K. Assay for blood plasma or serum methods in enzymology. Methods Enzymol 1984; 105: 328-337.
24. Tomizawa YJ. Clinical benefits and risk analysis of topical hemostats: a review. Artif Organs 2005; 8: 137-142.
25. Saravanan G, Ponmurugan P. Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats. Chemico-Biological Interactions 2011; 189: 100-106.
26. Ertürküner SP, Basar M, Tuncdemir M, Seckin I. The comparative effects of perindopril and catechin on mesangial matrix and podocytes in the streptozotocin induced diabetic rats. Pharmacological Reports 2014; 66: 279-287.
27. Kandhare AD, Ghosh P, Bodhankar SL. Naringin, a flavanone glycoside, promotes angiogenesis and inhibits endothelial apoptosis through modulation of inflammatory and growth factor expression in diabetic foot ulcer in rats. Chem Biol Interact 2014; 219: 101-112.
28. Singh J, Kakkar P. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats. Food Chem Toxicol 2013; 62: 722-731.
29. Lima TI, Monteiro IC, Valença S, Leal-Cardoso JH, Fortunato RS, Carvalho DP, Teodoro BG, Ceccatto VM. Effect of exercise training on liver antioxidant enzymes in STZ-diabetic rats. Life Sci 2015; 1: 64-71.
30. Kuo CW, Shen CJ, Tung YT, Chen HL, Chen YH, Chang WH, Cheng KC, Yang SH, Chen CM. Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS/ERK1/2 signaling. Life Sci 2015; 135: 77-86.
31. Chen F, Zhang H, Zhu J, Liu K, Cheng H, Li G, Xu S, Lv W, Xie Z. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. Asian Pac J Trop Med 2012; 5: 891-896.
32. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int 2002; 62: 901-913.
33. Brisset AE, Hom DB. The effects of tissue sealants, platelet gels, and growth factors on wound healing. Curr Opin Otolaryngol Head Neck Surg 2003; 11: 245-250.
34. Huri E, Akgül T, Yücel O, Astarcı M, Üstün H, Germiyanoğlu C. The second step in vitro trial of Ankaferd® Bloodstopper®: comparison with the other hemostatic agents. Turk J Med Sci 2011; 41: 7-15.
35. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001; 54: 176-186.
36. Llesuy S, Evelson P, González Flecha P, Peralta J, Carreras M, Poderoso J, Boveris A. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic Biol Med 1994; 16: 445- 451.
37. Lowry OH, Rosbrough NJ, Farr AL, Randall RJ. J. Protein measurement with the Folin phenol reagent. Biol Chem 1951; 193: 265.
38. Mylorie AA, Collins H, Umbles C, Kyle J. Erythrocyte superoxide dismutase activity and other parameters of cupper status in rats ingesting lead acetate. Toxicol Appl Pharmacol 1986; 82: 512-520.
39. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of Enzymatic Analysis. New York, NY, USA: Academic Press, 1974; pp. 673-677.
40. Loven D, Schedl H, Wilson H, Daabees TT, Stegink LD, Diekus M. Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin induced diabetes. Diabetes 1986; 35: 503-507.
41. Ewis SA, Abdel-Rahman MS. Effect of metformin on glutathione and magnesium in normal and streptozotocininduced diabetic rats. J Appl Toxicol 1995; 15: 387-390.
42. Saxena AK, Srivastava P, Kale RK, Baquer NZ. Impaired antioxidant status in diabetic rat liver: effect of vanadate. Biochem Pharmacol 1993; 45: 539-542.
43. Koluman A, Akar N, Malkan UY, Haznedaroglu IC. Qualitative/chemical analyses of Ankaferd hemostat and its antioxidant content in synthetic gastric fluids. Biomed Res Int 2016; 2016: 8957820. doi: 10.1155/2016/8957820.
44. Skalli O, Gabbiani G. The biology of the myofibroblast relationship to wound contraction and fibrocontractive disease. In: Clark RAF, Henson PM, editors. The Molecular and Cellular Biology of Wound Repair. New York, NY, USA: Plenum Press, 1988; pp. 373-402.
45. Evren C, Uğur MB, Yıldırım B, Bektaş S, Yiğit VB, Çınar F. Unpredicted effects of Ankaferd® on cartilage tissue. Int J Clin Exp Med 2015; 8: 922-927.